147 related articles for article (PubMed ID: 32870311)
1. Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer.
Fujii K; Sakanaka K; Uozumi R; Ishida Y; Inoo H; Tsunoda S; Miyamoto S; Muto M; Mizowaki T
JAMA Netw Open; 2020 Sep; 3(9):e2013952. PubMed ID: 32870311
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density loss in thoracic and lumbar vertebrae following radiation for abdominal cancers.
Wei RL; Jung BC; Manzano W; Sehgal V; Klempner SJ; Lee SP; Ramsinghani NS; Lall C
Radiother Oncol; 2016 Mar; 118(3):430-6. PubMed ID: 26993414
[TBL] [Abstract][Full Text] [Related]
3. Radiation field size and dose determine oncologic outcome in esophageal cancer.
Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Lee J; Lin JB; Sun FJ; Lu KW; Lee CH; Chen YJ; Huang WC; Liu HC; Wu MH
Br J Radiol; 2016 Oct; 89(1066):20160350. PubMed ID: 27556422
[TBL] [Abstract][Full Text] [Related]
5. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer.
Hasatani K; Tamamura H; Yamamoto K; Aoyagi H; Miyanaga T; Kaizaki Y; Sawada T
Digestion; 2020; 101(4):366-374. PubMed ID: 31067539
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
8. Association of radiotherapy with thoracic vertebral fractures in esophageal squamous cell carcinoma: A retrospective cohort study.
Wu XQ; Zhang TY; Yang F; Feng XY; Feng YL; Wang LL; Chen TW; Li CP; Li R
Medicine (Baltimore); 2023 Sep; 102(39):e35304. PubMed ID: 37773852
[TBL] [Abstract][Full Text] [Related]
9. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
[TBL] [Abstract][Full Text] [Related]
10. Gastric mucosal injury and hemorrhage after definitive chemoradiotherapy for locally advanced esophageal cancer.
Monma S; Kato K; Shouji H; Okita N; Takashima A; Honma Y; Iwasa S; Hamaguchi T; Yamada Y; Shimada Y; Boku N; Nagashima K; Ito Y; Itami J
Esophagus; 2019 Oct; 16(4):402-407. PubMed ID: 31222680
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes and prognostic factors for thoracic esophageal cancer with clinical evidence of adjacent organ invasion.
Hamai Y; Hihara J; Emi M; Taomoto J; Aoki Y; Kishimoto I; Ibuki Y; Okada M
Anticancer Res; 2013 Aug; 33(8):3495-502. PubMed ID: 23898125
[TBL] [Abstract][Full Text] [Related]
12. Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Hsu PK; Chen HS; Liu CC; Huang CS; Hsieh CC; Hsu HS; Wu SC
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):732-740.e2. PubMed ID: 28457536
[TBL] [Abstract][Full Text] [Related]
13. Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients.
Shien K; Yamashita M; Okazaki M; Suehisa H; Sawada S; Miyoshi S
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1002-6. PubMed ID: 21441256
[TBL] [Abstract][Full Text] [Related]
14. Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.
Deek MP; Benenati B; Kim S; Chen T; Ahmed I; Zou W; Aisner J; Jabbour SK
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):147-154. PubMed ID: 26700708
[TBL] [Abstract][Full Text] [Related]
15. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for vertebral compression fractures in preoperative chemoradiotherapy with gemcitabine for pancreatic cancer.
Otani K; Teshima T; Ito Y; Kawaguchi Y; Konishi K; Takahashi H; Ohigashi H; Oshima K; Araki N; Nishiyama K; Ishikawa O
Radiother Oncol; 2016 Mar; 118(3):424-9. PubMed ID: 26806264
[TBL] [Abstract][Full Text] [Related]
18. Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study.
Zhao Q; Hu G; Xiao W; Chen Y; Shen M; Tang Q; Ning X
Medicine (Baltimore); 2017 Sep; 96(35):e7920. PubMed ID: 28858114
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute.
Jing W; Guo H; Kong L; Zhang Y; Wang H; An C; Zhu H; Yu J
Medicine (Baltimore); 2016 Dec; 95(50):e5630. PubMed ID: 27977606
[TBL] [Abstract][Full Text] [Related]
20. Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer.
Anderson JL; Newman NB; Anderson C; Sherry AD; Yock AD; Osmundson EC
Radiother Oncol; 2020 Nov; 152():169-176. PubMed ID: 32291110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
